dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Gabriel Salazar, Marina |
dc.contributor.author | Lei (Santiago), Ting |
dc.contributor.author | Grayston Morales, Alba |
dc.contributor.author | Costa Riu, Carme |
dc.contributor.author | Medina Gutierrez, Esperanza |
dc.contributor.author | Montaner Villalonga, Joan |
dc.contributor.author | Rosell Novel, Anna |
dc.contributor.author | Comabella Lopez, Manuel |
dc.date.accessioned | 2022-02-21T09:44:05Z |
dc.date.available | 2022-02-21T09:44:05Z |
dc.date.issued | 2021-06-21 |
dc.identifier.citation | Gabriel-Salazar M, Lei T, Grayston A, Costa C, Medina-Gutiérrez E, Comabella M, et al. Angiogenin in the Neurogenic Subventricular Zone After Stroke. Front Neurol. 2021 Jun 21;12:941. |
dc.identifier.issn | 1664-2295 |
dc.identifier.uri | https://hdl.handle.net/11351/7042 |
dc.description | Angiogenina; Exercici; Neuroreparació |
dc.description.sponsorship | MG-S was supported by a pre-doctoral fellowship from the Vall d'Hebron Research Institute, AR was supported by the Miguel Servet program and AG holds a pre-doctoral fellowship both from Instituto Carlos III (CPII15/00003 and FI17/00073, respectively), and TL was supported by the China Scholarship Council (CSC-201706170048). This research has been funded by grants PI16/00981, PI19/00186, and RD16/0019/0021 (RETICS-INVICTUS PLUS) from the Instituto de Salud Carlos III co-financed by the European Regional Development Funds, and by the Generalitat de Catalunya (2017SGR 1427). |
dc.language.iso | eng |
dc.publisher | Frontiers Media |
dc.relation.ispartofseries | Frontiers in Neurology;12 |
dc.rights | Attribution 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ |
dc.source | Scientia |
dc.subject | Cèl·lules mare neurals |
dc.subject | Malalties cerebrovasculars - Tractament |
dc.subject.mesh | Neural Stem Cells |
dc.subject.mesh | Stroke |
dc.subject.mesh | /therapy |
dc.title | Angiogenin in the Neurogenic Subventricular Zone After Stroke |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.3389/fneur.2021.662235 |
dc.subject.decs | células madre nerviosas |
dc.subject.decs | accidente cerebrovascular |
dc.subject.decs | /terapia |
dc.relation.publishversion | https://doi.org/10.3389/fneur.2021.662235 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Gabriel-Salazar M, Lei T, Grayston A, Medina-Gutiérrez E, Montaner J, Rosell A] Laboratori de Recerca Neurovascular, Servei de Neurologia, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. [Costa C, Comabella M] Servei de Neurologia-Neuroimmunologia, Centre d'Esclerosi Múltiple de Catalunya (CEMCAT), Barcelona, Spain. Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain |
dc.identifier.pmid | 34234733 |
dc.identifier.wos | 000669466900001 |
dc.relation.projectid | info:eu-repo/grantAgreement/ES/PE2013-2016/CPII15%2F00003 |
dc.relation.projectid | info:eu-repo/grantAgreement/ES/PE2013-2016/FI17%2F00073 |
dc.relation.projectid | info:eu-repo/grantAgreement/ES/PE2013-2016/PI16%2F00981 |
dc.relation.projectid | info:eu-repo/grantAgreement/ES/PE2017-2020/PI19%2F00186 |
dc.relation.projectid | info:eu-repo/grantAgreement/ES/PE2013-2016/RD16%2F0019%2F0021 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |